PLGA-Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo.

Overview of attention for article published in Molecular Cancer Therapeutics, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 4,760 followers.

#ICYMI: PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo. https://t.co/pgIUgqxb0S https://t.co/ZaWTR96QZC

PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo. https://t.co/Woe1bbfliC https://t.co/4octWCpO9s

RRIDs were included in the Molecular Cancer Therapeutics paper "mct-22-0066-html.html" (https://t.co/I6dYZ8OAlu). RRIDs like this improve reproducibility in scientific research. #ReproducibleResearch #OpenScience

RT @NeuralCell: Disulfiram showed selective toxicity to #glioblastoma cells, eradicated glioblastoma stem cells, and blocked 🛡️ migration a…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.